Exploring the genetic basis of early-onset chronic kidney disease

Nature Reviews Nephrology

Volumn 12, Issue 3, 2016, Pages 133-146

  Vivante, Asaf ^a,b   Hildebrandt, Friedhelm ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGXT PROTEIN; ARHGDIA PROTEIN; CD2 ASSOCIATED PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1BETA; KANK1 PROTIEN; KANK2 PROTEIN; KANK4 PROTEIN; NEPHRIN; PODOCIN; POLYCYSTIN 1; POLYCYSTIN 2; PROTEIN; PROTEIN CDC42; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SLC4A1 PROTEIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; CHILD; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CONGENITAL ANOMALIES OF THE KIDNEYS AND URINARY TRACT; CONGENITAL NEPHROTIC SYNDROME; CONSANGUINITY; COPY NUMBER VARIATION; EARLY ONSET CHRONIC KIDNEY DISEASE; EDEMA; EXON; FOCAL GLOMERULOSCLEROSIS; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEMATURIA; HIGH THROUGHPUT SEQUENCING; HUMAN; HYPERLIPIDEMIA; HYPOALBUMINEMIA; INCIDENTAL FINDING; KIDNEY CALCIFICATION; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; NEPHRITIS; NEPHROLITHIASIS; NEPHRONOPHTHISIS; NEXT GENERATION SEQUENCING; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDIGREE; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; UNITED STATES; URINARY TRACT DISEASE; ADOLESCENT; ADULT; GENETICS; INFANT; ONSET AGE; PRESCHOOL CHILD; RENAL INSUFFICIENCY, CHRONIC; SEQUENCE ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; GENETIC TESTING; HUMANS; INFANT; RENAL INSUFFICIENCY, CHRONIC; SEQUENCE ANALYSIS; YOUNG ADULT;

EID: 84959053835     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2015.205     Document Type: Review

References (200)

1. Inker, L. A., et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am. J. Kidney Dis. 63, 713-735 (2014
2. Coresh, J., et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038-2047 (2007
3. Gee, H. Y., et al. Whole-exome resequencing distinguishes cystic kidney diseases from phenocopies in renal ciliopathies. Kidney Int. 85, 880-887 (2014
4. Devuyst, O., et al. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet 383, 1844-1859 (2014
5. Vivante, A., Kohl, S., Hwang, D. Y., Dworschak, G. C., & Hildebrandt, F. Single-gene causes of congenital anomalies of the kidney and urinary tract (CAKUT) in humans. Pediatr. Nephrol. 29, 695-704 (2014
6. Saisawat, P., et al. Whole-exome resequencing reveals recessive mutations in TRAP1 in individuals with CAKUT and VACTERL association. Kidney Int. 85, 1310-1317 (2014
7. Ebarasi, L., et al. Defects of CRB2 cause steroid-resistant nephrotic syndrome. Am. J. Hum. Genet. 96, 153-161 (2014
8. Lovric, S., et al. Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 9, 1109-1116 (2014
9. Kohl, S., et al. Mild recessive mutations in six Fraser syndrome-related genes cause isolated congenital anomalies of the kidney and urinary tract. J. Am. Soc. Nephrol. 25, 1917-1922 (2014
10. Hwang, D. Y., et al. Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. Kidney Int. 85, 1429-1433 (2014
11. Hildebrandt, F. Genetic kidney diseases. Lancet 375, 1287-1295 (2010
12. Smith, J. M., Stablein, D. M., Munoz, R., Hebert, D., & McDonald, R. A. Contributions of the Transplant Registry: the 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr. Transplant. 11, 366-373 (2007
13. Harambat, J., van Stralen, K. J., Kim, J. J., & Tizard, E. J. Epidemiology of chronic kidney disease in children. Pediatr. Nephrol. 27, 363-373 (2012
14. Kestila, M., et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol. Cell 1, 575-582 (1998
15. Wiggins, R. C. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 71, 1205-1214 (2007
16. Somlo, S., & Mundel, P. Getting a foothold in nephrotic syndrome. Nat. Genet. 24, 333-335 (2000
17. Vivante, A., et al. Mutations in TBX18 cause dominant urinary tract malformations via transcriptional dysregulation of ureter development. Am. J. Hum. Genet. 97, 291-301 (2015
18. Lovric, S., Ashraf, S., Tan, W., & Hildebrandt, F. Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol. Dial. Transplant. http://dx.doi.org/10.1093/ndt/gfv355 (2015
19. Trautmann, A., et al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin. J. Am. Soc. Nephrol. 10, 592-600 (2015
20. Hildebrandt, F., Benzing, T., & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364, 1533-1543 (2011
21. Altshuler, D., Daly, M. J., & Lander, E. S. Genetic mapping in human disease. Science 322, 881-888 (2008
22. Chaki, M., et al. Genotype-phenotype correlation in 440 patients with NPHP-related ciliopathies. Kidney Int. 80, 1239-1245 (2011
23. Palumbo, P., et al. Variable phenotype in 17q12 microdeletions: clinical and molecular characterization of a new case. Gene 538, 373-378 (2014
24. Chen, Y. Z., et al. Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5. Chinese Med. J. 123, 3326-3333 (2010
25. Hasselbacher, K., et al. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2 associated disorders. Kidney Int. 70, 1008-1012 (2006
26. Tory, K., et al. Mutation-dependent recessive inheritance of NPHS2 associated steroid-resistant nephrotic syndrome. Nat. Genet. 46, 299-304 (2014
27. Genovese, G., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841-845 (2010
28. Tzur, S., et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum. Genet. 128, 345-350 (2010
29. Freedman, B. I., et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J. Am. Soc. Nephrol. 21, 1422-1426 (2010
30. Friedman, D. J., Kozlitina, J., Genovese, G., Jog, P., & Pollak, M. R. Population-based risk assessment of APOL1 on renal disease. J. Am. Soc. Nephrol. 22, 2098-2105 (2011
31. Genovese, G., et al A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int. 78, 698-704 (2010
32. Dummer, P. D., et al. APOL1 kidney disease risk variants: an evolving landscape. Seminars Nephrol. 35, 222-236 (2015
33. Kopp, J. B., et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-Associated nephropathy. J. Am. Soc. Nephrol. 22, 2129-2137 (2011
34. Khanna, H., et al. A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies. Nat. Genet. 41, 739-745 (2009
35. Deltas, C., Pierides, A., & Voskarides, K. Molecular genetics of familial hematuric diseases. Nephrol. Dial. Transplant. 28, 2946-2960 (2013
36. MacArthur, D. G., et al. Guidelines for investigating causality of sequence variants in human disease. Nature 508, 469-476 (2014
37. Bell, C. J., et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci. Transl. Med. 3, 65ra64 (2011
38. Richards, S., et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405-424 (2015
39. Sanna-Cherchi, S., et al. Mutations in DSTYK and dominant urinary tract malformations. N. Engl. J. Med. 369, 621-629 (2013
40. Sethi, S., & Fervenza, F. C. Membranoproliferative glomerulonephritis-A new look at an old entity. N. Engl. J. Med. 366, 1119-1131 (2012
41. Halbritter, J., et al. High-Throughput mutation analysis in patients with a nephronophthisis-Associated ciliopathy applying multiplexed barcoded array-based PCR amplification and next-generation sequencing. J. Med. Genet. 49, 756-767 (2012
42. Halbritter, J., et al. Identification of 99 novel mutations in a worldwide cohort of 1, 056 patients with a nephronophthisis-related ciliopathy. Hum. Genet. 132, 865-884 (2013
43. George, J. N., & Nester, C. M. Syndromes of thrombotic microangiopathy. N. Engl. J. Med. 371, 654-666 (2014
44. Sadowski, C. E., et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1279-1289 (2015
45. Halbritter, J., et al. Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J. Am. Soc. Nephrol. 26, 543-551 (2014
46. Braun, D. A., et al. Whole exome sequencing identifies causative mutations in the majority of consanguineous or familial cases with childhood-onset increased renal echogenicity. Kidney Int. http://dx.doi.org/10.1038/ki.2015.317 (2015
47. Sanna-Cherchi, S., et al. Copy-number disorders are a common cause of congenital kidney malformations. Am. J. Hum. Genet. 91, 987-997 (2012
48. Weber, S., et al. Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization. Nephrol. Dial. Transplant. 26, 136-143 (2011
49. Ruf, R. G., et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J. Am. Soc. Nephrol. 15, 722-732 (2004
50. Weber, S., et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-Transplant recurrence. Kidney Int. 66, 571-579 (2004
51. Chernin, G., et al. Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations. Clin. J. Am. Soc. Nephrol. 5, 1655-1662 (2010
52. Montini, G., Malaventura, C., & Salviati, L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N. Engl. J. Med. 358, 2849-2850 (2008
53. Heeringa, S. F., et al. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 121, 2013-2024 (2011
54. Ashraf, S., et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J. Clin. Invest. 123, 5179-5189 (2013
55. Gee, H. Y., et al. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J. Clin. Invest. 123, 3243-3253 (2013
56. Gee, H. Y., et al. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J. Clin. Invest. 125, 2375-2384 (2015
57. Faul, C., et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat. Med. 14, 931-938 (2008
58. Hinkes, B., et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat. Genet. 38, 1397-1405 (2006
59. Moriniere, V., et al. Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J. Am. Soc. Nephrol. 25, 2740-2751 (2014
60. Harris, P. C., & Rossetti, S. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat. Rev. Nephrology 6, 197-206 (2010
61. Pearle, M. S., et al. Medical management of kidney stones: AUA guideline. J. Urol. 192, 316-324 (2014
62. Staiger, K., et al. Hypomagnesemia and nephrocalcinosis in a patient with two heterozygous mutations in the CLDN16 gene. J. Nephrol. 20, 107-110 (2007
63. Otto, E. A., et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat. Genet. 42, 840-850 (2010
64. Giglio, S., et al. Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J. Am. Soc. Nephrol. 26, 230-236 (2015
65. Boyer, O., et al. Mutational analysis of the PLCE1 gene in steroid resistant nephrotic syndrome. J. Med. Genet. 47, 445-452 (2010
66. Lipska, B. S., et al. Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int. 84, 206-213 (2013
67. Ross, L. F., et al. Technical report: ethical and policy issues in genetic testing and screening of children. Genet. Med. 15, 234-245 (2013
68. Mardis, E. R. The impact of next-generation sequencing technology on genetics. Trends Genet. 24, 133-141 (2008
69. Koboldt, D. C., Steinberg, K. M., Larson, D. E., Wilson, R. K., & Mardis, E. R. The next-generation sequencing revolution and its impact on genomics. Cell 155, 27-38 (2013
70. Hildebrandt, F., et al. A systematic approach to mapping recessive disease genes in individuals from outbred populations. PLoS Genet. 5, e1000353 (2009
71. Green, R. C., et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 5, 565-574 (2013
72. Yang, Y., et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 312, 1870-1879 (2014
73. Lee, H., et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 312, 1880-1887 (2014
74. Boute, N., et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24, 349-354 (2000
75. Lowik, M. M., et al. Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int. 72, 1198-1203 (2007
76. Kaplan, J. M., et al. Mutations in ACTN4, encoding α-Actinin 4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24, 251-256 (2000
77. Brown, E. J., et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat. Genet. 42, 72-76 (2010
78. Zenker, M., et al. Human laminin β2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum. Mol. Genet. 13, 2625-2632 (2004
79. Gee, H. Y., et al. Mutations in EMP2 cause childhood-onset nephrotic syndrome. Am. J. Hum. Genet. 94, 884-890 (2014
80. Diomedi-Camassei, F., et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J. Am. Soc. Nephrol. 18, 2773-2780 (2007
81. Ozaltin, F. Primary coenzyme Q10 (CoQ10) deficiencies and related nephropathies. Pediatr. Nephrol. 29, 961-969 (2014
82. Salviati, L., et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10 responsive condition. Neurology 65, 606-608 (2005
83. Rotig, A., et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356, 391-395 (2000
84. Saisawat, P., et al. Identification of two novel CAKUT-causing genes by massively parallel exon resequencing of candidate genes in patients with unilateral renal agenesis. Kidney Int. 81, 196-200 (2012
85. Bettencourt-Dias, M., Hildebrandt, F., Pellman, D., Woods, G., & Godinho, S. A. Centrosomes and cilia in human disease. Trends Genet. 27, 307-315 (2011
86. Hildebrandt, F., Attanasio, M., & Otto, E. Nephronophthisis: disease mechanisms of a ciliopathy. J. Am. Soc. Nephrol. 20, 23-35 (2009
87. Lemaire, M., et al. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat. Genet. 45, 531-536 (2013
88. Neumann, H. P., et al. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J. Med. Genet. 40, 676-681 (2003
89. Noris, M., et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin. J. Am. Soc. Nephrol. 5, 1844-1859 (2010
90. Westra, D., et al. Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H related 5 gene. J. Hum. Genet. 57, 459-464 (2012
91. Goldfarb, D. S. The search for monogenic causes of kidney stones. J. Am. Soc. Nephrol. 26, 507-510 (2015
92. Weber, S., et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J. Am. Soc. Nephrol. 19, 891-903 (2008
93. Brockschmidt, A., et al. CHD1L: a new candidate gene for congenital anomalies of the kidneys and urinary tract (CAKUT). Nephrol. Dial. Transplant. 27, 2355-2364 (2012
94. Abdelhak, S., et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat. Genet. 15, 157-164 (1997
95. Pandolfi, P. P., et al. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11, 40-44 (1995
96. Van Esch, H., et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406, 419-422 (2000
97. Lindner, T. H., et al. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor 1β. Hum. Mol. Genet. 8, 2001-2008 (1999
98. Kirby, A., et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat. Genet. 45, 299-303 (2013
99. Sanyanusin, P., McNoe, L. A., Sullivan, M. J., Weaver, R. G., & Eccles, M. R. Mutation of PAX2 in two siblings with renal-coloboma syndrome. Hum. Mol. Genet. 4, 2183-2184 (1995
100. Skinner, M. A., et al. Renal aplasia in humans is associated with RET mutations. Am. J. Hum. Genet. 82, 344-351 (2008
101. Lu, W., et al. Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux. Am. J. Hum. Genet. 80, 616-632 (2007
102. Kohlhase, J., Wischermann, A., Reichenbach, H., Froster, U., & Engel, W. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nat. Genet. 18, 81-83 (1998
103. Ruf, R. G., et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc. Natl Acad. Sci. USA 101, 8090-8095 (2004
104. Hoskins, B. E., et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am. J. Hum. Genet. 80, 800-804 (2007
105. Gimelli, S., et al. Mutations in SOX17 are associated with congenital anomalies of the kidney and the urinary tract. Hum. Mut. 31, 1352-1359 (2010
106. Hwang, D. Y., et al. Mutations of the SLIT2-ROBO2 pathway genes SLIT2 and SRGAP1 confer risk for congenital anomalies of the kidney and urinary tract. Hum. Genet. 134, 905-916 (2015
107. Gbadegesin, R. A., et al. TNXB mutations can cause vesicoureteral reflux. J. Am. Soc. Nephrol. 24, 1313-1322 (2013
108. Hart, T. C., et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J. Med. Genet. 39, 882-892 (2002
109. Jenkins, D., et al. De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure. J. Am. Soc. Nephrol. 16, 2141-2149 (2005
110. Biason-Lauber, A., Konrad, D., Navratil, F., & Schoenle, E. J. A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46, XX woman. N. Engl. J. Med. 351, 792-798 (2004
111. Mandel, H., et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss of function mutation in WNT4. Am. J. Hum. Genet. 82, 39-47 (2008
112. Vivante, A., et al. Renal hypodysplasia associates with a WNT4 variant that causes aberrant canonical Wnt signaling. J. Am. Soc. Nephrol. 24, 550-558 (2013
113. Gribouval, O., et al. Mutations in genes in the renin-Angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat. Genet. 37, 964-968 (2005
114. Weber, S., et al. Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome. Am. J. Hum. Genet. 89, 668-674 (2011
115. Barak, H., et al. FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. Dev. Cell 22, 1191-1207 (2012
116. McGregor, L., et al. Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat. Genet. 34, 203-208 (2003
117. Bulum, B., et al. HPSE2 mutations in urofacial syndrome, non-neurogenic neurogenic bladder and lower urinary tract dysfunction. Nephron 130, 54-58 (2015
118. Humbert, C., et al. Integrin alpha 8 recessive mutations are responsible for bilateral renal agenesis in humans. Am. J. Hum. Genet. 94, 288-294 (2014
119. Stuart, H. M., et al. LRIG2 mutations cause urofacial syndrome. Am. J. Hum. Genet. 92, 259-264 (2013
120. Hardelin, J. P., et al. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc. Natl Acad. Sci. USA 89, 8190-8194 (1992
121. Shih, N. Y., et al. Congenital nephrotic syndrome in mice lacking CD2 associated protein. Science 286, 312-315 (1999
122. Sethi, S., Fervenza, F. C., Zhang, Y., & Smith, R. J. Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3. Am. J. Kidney Dis. 60, 316-321 (2012
123. Ovunc, B., et al. Exome sequencing reveals cubilin mutation as a single-gene cause of proteinuria. J. Am. Soc. Nephrol. 22, 1815-1820 (2011
124. Ozaltin, F., et al. DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J. Am. Soc. Nephrol. 24, 377-384 (2013
125. Has, C., et al. Integrin α3 mutations with kidney, lung, and skin disease. N. Engl. J. Med. 366, 1508-1514 (2012
126. Kambham, N., et al. Congenital focal segmental glomerulosclerosis associated with beta4 integrin mutation and epidermolysis bullosa. Am. J. Kidney Dis. 36, 190-196 (2000
127. Yasukawa, T., et al. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 275, 4251-4257 (2000
128. Mele, C., et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N. Engl. J. Med. 365, 295-306 (2011
129. Miyake, N., et al. Biallelic mutations in nuclear pore complex subunit nup107 cause early-childhood-onset steroid-resistant nephrotic syndrome. Am. J. Hum. Genet. 97, 555-566 (2015
130. Lopez, L. C., et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 79, 1125-1129 (2006
131. Ozaltin, F., et al. Disruption of PTPRO causes childhood-onset nephrotic syndrome. Am. J. Hum. Genet. 89, 139-147 (2011
132. Berkovic, S. F., et al. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP 2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am. J. Hum. Genet. 82, 673-684 (2008
133. Boerkoel, C. F., et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat. Genet. 30, 215-220 (2002
134. Colin, E., et al. Loss of function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome. Am. J. Hum. Genet. 95, 637-648 (2014
135. Vodopiutz, J., et al. WDR73 mutations cause infantile neurodegeneration and variable glomerular kidney disease. Hum. Mut. 36, 1021-1028 (2015
136. Jinks, R N., et Al. Recessive Nephrocerebellar Syndrome on the Galloway-Mowat Syndrome Spectrum Is Caused by Homozygous Protein-Truncating Mutations of WDR73. Brain 138, 2173-2190 (2015
137. Gbadegesin, R. A., et al. Mutations in the gene that encodes the F actin binding protein anillin cause FSGS. J. Am. Soc. Nephrol. 25, 1991-2002 (2014
138. Akilesh, S., et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J. Clin. Invest. 121, 4127-4137 (2011
139. McIntosh I., et al. Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am. J. Hum. Genet. 63, 1651-1658 (1998
140. Heath, K. E., et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am. J. Hum. Genet. 69, 1033-1045 (2001
141. Winn, M. P., et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801-1804 (2005
142. Reiser, J., et al. TRPC6 is a glomerular slit diaphragm-Associated channel required for normal renal function. Nat. Genet. 37, 739-744 (2005
143. Jeanpierre, C., et al. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am. J. Hum. Genet. 62, 824-833 (1998
144. Fremeaux-Bacchi, V., et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J. Med. Genet. 41, e84 (2004
145. McRae, J. L., et al. Human factor H related protein 5 (FHR 5). A new complement-Associated protein. J. Biol. Chem. 276, 6747-6754 (2001
146. Gale, D. P., et al. Identification of a mutation in complement factor H related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376, 794-801 (2010
147. Athanasiou, Y., et al. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin. J. Am. Soc. Nephrol.: CJASN 6, 1436-1446 (2011
148. Castelletti, F., et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proc. Natl Acad. Sci. USA 105, 2538-2543 (2008
149. Mochizuki, T., et al. Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat. Genet. 8, 77-81 (1994
150. Marcocci, E., et al. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Nephrol. Dial. Transplant. 24, 1464-1471 (2009
151. Noris, M., et al. Familial haemolytic uraemic syndrome and an MCP mutation. Lancet 362, 1542-1547 (2003
152. Knebelmann, B., et al. Spectrum of mutations in the COL4A5 collagen gene in X linked Alport syndrome. Am. J. Hum. Genet. 59, 1221-1232 (1996
153. Anker, M. C., et al. Alport syndrome with diffuse leiomyomatosis. Am. J. Med. Genet. 119A, 381-385 (2003
154. Hildebrandt, F., et al. A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1. Nat. Genet. 17, 149-153 (1997
155. Saunier, S., et al. A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis. Hum. Mol. Genet. 6, 2317-2323 (1997
156. Otto, E. A., et al. Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination. Nat. Genet. 34, 413-420 (2003
157. Olbrich, H., et al. Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat. Genet. 34, 455-459 (2003
158. Otto, E., et al. A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution. Am. J. Hum. Genet. 71, 1167-1171 (2002
159. Delous, M., et al. Nephrocystin 1 and nephrocystin 4 are required for epithelial morphogenesis and associate with PALS1/PATJ and Par6. Hum. Mol. Genet. 18, 4711-4723 (2009
160. Otto, E. A., et al. Nephrocystin 5, a ciliary IQ domain protein, is mutated in Senior-Løken syndrome and interacts with RPGR and calmodulin. Nat. Genet. 37, 282-288 (2005
161. Sayer, J. A., et al. The centrosomal protein nephrocystin 6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat. Genet. 38, 674-681 (2006
162. Attanasio, M., et al. Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat. Genet. 39, 1018-1024 (2007
163. Delous, M., et al. The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat. Genet. 39, 875-881 (2007
164. Otto, E. A., et al. NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis. J. Am. Soc. Nephrol. 19, 587-592 (2008
165. Otto, E. A., et al. Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11). J. Med. Genet. 46, 663-670 (2009
166. Davis, E. E., et al. TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nat. Genet. 43, 189-196 (2011
167. Coussa, R. G., et al. WDR19: an ancient, retrograde, intraflagellar ciliary protein is mutated in autosomal recessive retinitis pigmentosa and in Senior-Løken syndrome. Clin. Genet. 84, 150-159 (2013
168. Chaki, M., et al. Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell 150, 533-548 (2012
169. Hoff, S., et al. ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nat. Genet. 45, 951-956 (2013
170. Reed, B. Y., et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J. Clin. Endocrinol. Metab. 87, 1476-1485 (2002
171. Purdue, P. E., Allsop, J., Isaya, G., Rosenberg, L. E., & Danpure, C. J. Mistargeting of peroxisomal l alanine: glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation. Proc. Natl Acad. Sci. USA 88, 10900-10904 (1991
172. Hidaka, Y., Palella, T. D., OToole, T. E., Tarle, S. A., & Kelley, W. N. Human adenine phosphoribosyltransferase. Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme. J. Clin. Invest. 80, 1409-1415 (1987
173. Stover, E. H., et al. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J. Med. Genet. 39, 796-803 (2002
174. Karet, F. E., et al. Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat. Genet. 21, 84-90 (1999
175. Venta, P. J., Welty, R. J., Johnson, T. M., Sly, W. S., & Tashian, R. E. Carbonic anhydrase II deficiency syndrome in a Belgian family is caused by a point mutation at an invariant histidine residue (107 His-Tyr): complete structure of the normal human CA II gene. Am. J. Hum. Genet. 49, 1082-1090 (1991
176. Pearce, S. H., et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N. Engl. J. Med. 335, 1115-1122 (1996
177. Lloyd, S. E., et al. A common molecular basis for three inherited kidney stone diseases. Nature 379, 445-449 (1996
178. Simon, D. B., et al. Mutations in the chloride channel gene, CLCNKB, cause Bartters syndrome type III. Nat. Genet. 17, 171-178 (1997
179. Simon, D. B., et al. Paracellin 1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285, 103-106 (1999
180. Konrad, M., et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am. J. Hum. Genet. 79, 949-957 (2006
181. Schlingmann, K. P., et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J. Med. 365, 410-421 (2011
182. Jaureguiberry, G., et al. Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations. Nephron Physiol. 122, 1-6 (2012
183. Cramer, S. D., Ferree, P. M., Lin, K., Milliner, D. S., & Holmes, R. P. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum. Mol. Genet. 8, 2063-2069 (1999
184. Hamilton, A. J., et al. The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype. J. Med. Genet. 51, 165-169 (2014
185. Belostotsky, R., et al. Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am. J. Hum. Genet. 87, 392-399 (2010
186. Davidson, B. L., et al. Identification of 17 independent mutations responsible for human hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Am. J. Hum. Genet. 48, 951-958 (1991
187. Simon, D. B., et al. Genetic heterogeneity of Bartters syndrome revealed by mutations in the K+ channel, ROMK. Nat. Genet. 14, 152-156 (1996
188. Reilly, D. S., Lewis, R. A., Ledbetter, D. H., & Nussbaum, R. L. Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment. Am. J. Hum. Genet. 42, 748-755 (1988
189. Simon, D. B., et al. Bartters syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat. Genet. 13, 183-188 (1996
190. Enomoto, A., et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417, 447-452 (2002
191. Matsuo, H., et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am. J. Hum. Genet. 83, 744-751 (2008
192. Prie, D., et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N. Engl. J. Med. 347, 983-991 (2002
193. Lorenz-Depiereux, B., et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am. J. Hum. Genet. 78, 193-201 (2006
194. Calonge, M. J., et al. Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat. Genet. 6, 420-425 (1994
195. Bruce, L. J., et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J. Clin. Invest. 100, 1693-1707 (1997
196. Feliubadalo, L., et al. Non-Type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo, +AT) of rBAT. Nat. Genet. 23, 52-57 (1999
197. Karim, Z., et al. NHERF1 mutations and responsiveness of renal parathyroid hormone. N. Engl. J. Med. 359, 1128-1135 (2008
198. Scott, P., et al. Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J. Am. Soc. Nephrol. 10, 1007-1013 (1999
199. Ichida, K., et al. Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. J. Clin. Invest. 99, 2391-2397 (1997
200. Wainwright, C. E., et al. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N. Engl. J. Med. 373, 220-231 (2015